Table 2.
Tool | N* | n (%) adverse outcome† | C-statistic | Threshold | n (%) above threshold | Sensitivity | Specificity | PPV | NPV |
CRB-65 | 7469 | 1315 (18) | 0.79 (0.78 to 0.80) |
>0 | 4010 (54) | 0.89 (0.88 to 0.89) |
0.54 (0.53 to 0.54) |
0.29 (0.29 to 0.30) |
0.96 (0.95 to 0.96) |
NEWS2 | 7433 | 1315 (18) | 0.80 (0.78 to 0.81) |
>1 | 5574 (75) | 0.96 (0.96 to 0.96) |
0.30 (0.29 to 0.30) |
0.23 (0.22 to 0.23) |
0.97 (0.97 to 0.97) |
PMEWS | 7460 | 1315 (18) | 0.81 (0.80 to 0.83) |
>2 | 5352 (72) | 0.98 (0.97 to 0.98) |
0.34 (0.33 to 0.34) |
0.24 (0.24 to 0.24) |
0.99 (0.98 to 0.99) |
PRIEST | 7471 | 1315 (18) | 0.83 (0.82 to 0.84) |
>4 | 4932 (66) | 0.97 (0.97 to 0.97) |
0.41 (0.40 to 0.41) |
0.26 (0.25 to 0.26) |
0.98 (0.98 to 0.99) |
WHO | 7471 | 1315 (18) | 0.64 (0.64 to 0.65) |
>0 | 5539 (74) | 0.98 (0.97 to 0.98) |
0.31 (0.30 to 0.31) |
0.23 (0.23 to 0.24) |
0.98 (0.98 to 0.99) |
*Patients with less than three parameters were excluded from analysis when estimating performance.
†Totals rounded to nearest 5.
NEWS2, National Early Warning Score, version 2; NPV, negative predictive value; PPV, positive predictive value.